Patents by Inventor Maha Khaled

Maha Khaled has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070123593
    Abstract: The invention relates to a composition for the treatment of a cyclooxygenase-2-mediated disorder or condition comprising 5-methyl-2-(2?-chloro-6?-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt, preferably the potassium salt, thereof suitable for parenteral administration, and to a method for the treatment of a cyclooxygenase-2-mediated disorder or condition in a human or animal in need of such treatment by parenteral administration of 5-methyl-2-(2?-chloro-6?-fluroanilino)phenylacetic acid or a pharmaceutically acceptable salt, preferably the potassium salt, thereof.
    Type: Application
    Filed: October 7, 2004
    Publication date: May 31, 2007
    Inventors: Rose-Marie Dannenfelser, Vivian Georgousis, Maha Khaled, Tarun Patel, Joseph Sikora, Barbara Wang
  • Publication number: 20070087051
    Abstract: A method of treating a cyclooxygenase-2 dependent disorder or condition comprising administering a solid formulation of 5-methyl-2-(2?-chloro-6?-fluoroanilino)phenylacetic acid which has a residual moisture within predetermined levels.
    Type: Application
    Filed: December 14, 2006
    Publication date: April 19, 2007
    Inventors: Jurij Holinej, Yatindra Joshi, Anees Karnachi, Maha Khaled
  • Publication number: 20060094787
    Abstract: Provided are compositions comprising aqueous suspensions of 5-methyl-2-(2?-chloro-6?-fluoroanilino)phenylacetic acid suitable for oral administration. Methods for making such compositions and methods for their stabilization are provided.
    Type: Application
    Filed: March 11, 2004
    Publication date: May 4, 2006
    Inventors: Patrick Forenzo, Maha Khaled, Barbara Wang, Joseph Zielinski
  • Publication number: 20050123604
    Abstract: A method of treating a cyclooxygenase-2 dependent disorder or condition comprising administering 5-methyl-2-(2?-chloro-6?-fluoroanilino)phenylacetic acid in an amount effective to treat such a disorder or condition for about 24 hours, comprising administering orally once a day to a human in need of such treatment one or more immediate release pharmaceutical compositions comprising 5-methyl-2-(2?-chloro-6?-fluoroanilino)phenylacetic acid, and compositions suitable for use in such methods.
    Type: Application
    Filed: March 6, 2003
    Publication date: June 9, 2005
    Inventors: Anees Karnachi, Maha Khaled, Jurij Holinej, Yatindra Joshi